While advanced age and comorbidities are well-known risk factors for severe illness caused by COVID-19, it was still not understood why some people became gravely ill, whereas other patients of similar backgrounds recovered quickly.…

Candida albicans infections in the mouth are often painful for people who develop infections such as burning mouth syndrome or thrush.

United States pharmaceutical giant, Pfizer, whose two-shot COVID-19 vaccine recently showed 90% effectiveness in preliminary studies, is ready to roll out millions of doses as soon as it receives approval from the US Food and Drug…

NYU College of Dentistry (NYU Dentistry) has opened a new dental care practice in Downtown Brooklyn’s City Point. The practice brings high quality, low-cost dental care for adults and children to the Brooklyn community and its surrounding…

As we celebrate our 100th episode of The Art of Dental Finance and Management podcast, Art welcomes Dr. Kathleen O’Loughlin, Executive Director of the American Dental Association (ADA).

A new study found that patients who recovered from COVID-19 were at elevated risk for mental illness. Published in the British medical journal The Lancet, results demonstrated that one in five patients who had recovered from a SARS-CoV-2…

On November 9, the United States Food and Drug Administration issued an emergency use authorization (EUA) to bamlanivimab for the treatment of mild-to-moderate COVID-19. The monoclonal antibody therapy is authorized for COVID-19 patients…

Algonquin, Illinois, USA, November 10th, 2020 – Young Innovations, a leading global supplier of dental products, today announced the acquisition of Preat Corporation. Based in Santa Maria, CA, Preat is a leading provider of dental implant…

The American pharmaceutical company Pfizer reported that its COVID-19 vaccine is highly effective in preventing infection with the novel coronavirus in preliminary studies. In light of rising case numbers across the United States, this is…

Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level.  This product may be…